DFTX
Definium Therapeutics, Inc.
NASDAQ · USHealthcareMedical - Pharmaceuticals
$42.80-3.36%
Price as of Jul 20, 2026
DFTX capital
Definium Therapeutics, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.94x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 1.18x
Liquidity & coverage
- Current ratio
- 4.69x
- Quick ratio
- 4.69x
- Cash ratio
- 4.60x
- Interest coverage
- -13.29x
- EBITDA / interest
- -15.28x
- Working capital
- $299.5M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.